Connection
Colleen McIlvennan to Prospective Studies
This is a "connection" page, showing publications Colleen McIlvennan has written about Prospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.150 |
|
|
|
-
McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant. 2019 04; 38(4):374-381.
Score: 0.074
-
McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
Score: 0.055
-
Deininger KM, Tsunoda SM, Hirsch JD, Anderson H, Lee YM, McIlvennan CK, Page RL, Tran JN, Aquilante CL. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation. Clin Transplant. 2020 10; 34(10):e14037.
Score: 0.021